Latest News
Vivos Therapeutics, Inc.
- Form 8K Vivos Therapeutics Inc For: 21 October By Investing.com
- Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
- Vivos Therapeutics acquires stake in SOD Sciences
- Vivos Therapeutics Acquires Stake in SOD Sciences and Half Interest in Pseudohypoxia Early-Warning Test
- A deal gives Vivos half of a test; reaching more than 325,000 patients still depends on agreements and court approval.
- Vivos Therapeutics Exchanges $12M Series C Preferred for 11% of SOD Sciences and 50% Test IP
- $Vivos Therapeutics (VVOS.US)$
- Vivos Therapeutics Inc. (VVOS) Key Financial Ratios – Valuation, Profitability & More
- Vivos Therapeutics to acquire minority stake in SOD Sciences in $12M stock transaction
- Vivos Therapeutics to Acquire 11% Stake in SOD Sciences in $12M Stock Deal
- A $12 million stated-value share exchange would give Vivos half of a sleep-related test.
Headlines from the last 30 days, linking to the original publishers. See all market news →